These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19424212)

  • 1. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry links boost research output.
    Savage N
    Nature; 2017 Dec; 552(7683):S11-S13. PubMed ID: 29220000
    [No Abstract]   [Full Text] [Related]  

  • 3. Papers to patents.
    Arora A; Belenzon S; Patacconi A
    Nature; 2017 Dec; 552(7683):S10. PubMed ID: 29219977
    [No Abstract]   [Full Text] [Related]  

  • 4. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 5. Industry in academia: transparency alone is not enough.
    Lawry T
    Nature; 2010 Mar; 464(7288):486. PubMed ID: 20336110
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 7. Universities shun Europe's drug initiative.
    Gilbert N
    Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
    [No Abstract]   [Full Text] [Related]  

  • 8. Academic-industry partnerships 2012.
    Huggett B
    Nat Biotechnol; 2013 May; 31(5):383. PubMed ID: 23657385
    [No Abstract]   [Full Text] [Related]  

  • 9. Global strategic partnerships in regenerative medicine.
    French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA
    Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Property rights go East.
    Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959
    [No Abstract]   [Full Text] [Related]  

  • 11. Open-source science makes headway.
    Patlak M
    J Natl Cancer Inst; 2010 Aug; 102(16):1221-3. PubMed ID: 20693461
    [No Abstract]   [Full Text] [Related]  

  • 12. Cementing links between industry and the university.
    Jennings R
    Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
    [No Abstract]   [Full Text] [Related]  

  • 13. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 15. To the G20: incentivising antibacterial research and development.
    Årdal C; Baraldi E; Ciabuschi F; Outterson K; Rex JH; Piddock LJV; Findlay D;
    Lancet Infect Dis; 2017 Aug; 17(8):799-801. PubMed ID: 28689703
    [No Abstract]   [Full Text] [Related]  

  • 16. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
    McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
    Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entrepreneurship in the medical academy: possibilities and challenges in commercialization of research discoveries.
    Loscalzo J
    Circulation; 2007 Mar; 115(12):1504-7. PubMed ID: 17389277
    [No Abstract]   [Full Text] [Related]  

  • 18. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer.
    Witty A
    Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425
    [No Abstract]   [Full Text] [Related]  

  • 20. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K
    Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.